Attached files

file filename
EX-99.1 - WINNER MEDICAL GROUP INCv204684_ex99-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 


FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): December 6, 2010 (December 2, 2010)
 

 
WINNER MEDICAL GROUP INC.
(Exact Name of Registrant as Specified in its Charter)

Nevada
 
001-34484
 
33-0215298
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer
Identification No.)
 
Winner Industrial Park, Bulong Road
Longhua, Shenzhen City, 518109
The People’s Republic of China
(Address of principal executive offices, including zip code)
 
(86) 755 2813-8888
(Registrant’s telephone number, including area code)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 

 

Item 8.01       Other Events
 
On December 2, 2010, Winner Medical Group Inc. (the “Company”), issued a press release announcing that it will release its results for the fourth quarter and fiscal year 2010 on Wednesday, December 8, 2010.  The Company will host a management conference call to discuss the results at 5:30 a.m. (Pacific)/8:30 a.m. (Eastern)/9:30 p.m. (Shenzhen/Hong Kong) on Wednesday, December 2, 2010. The press release is attached as Exhibit 99.1 to this report on Form 8-K.
 
Item 9.01       Financial Statements and Exhibits
 
Exhibit No.
 
Description
99.1
 
Press Release of Winner Medical Group Inc. dated December 2, 2010
 
 
2

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Winner Medical Group Inc.
     
Date:      December 2, 2010
By:
/s/ Jianquan Li
   
Jianquan Li
   
President and Chief Executive Officer
 
 
3